shutterstock_452099194_brianpirwin

brianpirwin / Shutterstock.com

22 February 2019Americas

Indivior to launch generic after SCOTUS refuses petition

Indivior has launched a generic version of its opioid addiction drug Suboxone (buprenorphine and naloxone) Film, one day after the US Supreme Court denied its request to put a lower court’s ruling on hold.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Fed Circuit refusal paves way for Suboxone generics

5 February 2019 Rivals of British pharmaceutical company Indivior will soon be able to sell generic versions of opioid addiction treatment Suboxone film following a ruling of the US Court of Appeals for the Federal Circuit.

Indivior loses battle over Suboxone generic

22 November 2018 The US Court of Appeals for the Federal Circuit vacated a preliminary injunction against India-based Dr Reddy’s earlier this week, in a blow for addiction treatment drug producer Indivior.

Reckitt Benckiser to pay $1.4bn over opioid treatment sales

12 July 2019 Reckitt Benckiser has agreed to pay a $1.4 billion fine to settle a US investigation into the sales and marketing of opioid addiction treatment Suboxone film by its former prescriptions business.

More on this story

Fed Circuit refusal paves way for Suboxone generics

5 February 2019 Rivals of British pharmaceutical company Indivior will soon be able to sell generic versions of opioid addiction treatment Suboxone film following a ruling of the US Court of Appeals for the Federal Circuit.

Indivior loses battle over Suboxone generic

22 November 2018 The US Court of Appeals for the Federal Circuit vacated a preliminary injunction against India-based Dr Reddy’s earlier this week, in a blow for addiction treatment drug producer Indivior.

Reckitt Benckiser to pay $1.4bn over opioid treatment sales

12 July 2019 Reckitt Benckiser has agreed to pay a $1.4 billion fine to settle a US investigation into the sales and marketing of opioid addiction treatment Suboxone film by its former prescriptions business.

More on this story

Fed Circuit refusal paves way for Suboxone generics

5 February 2019 Rivals of British pharmaceutical company Indivior will soon be able to sell generic versions of opioid addiction treatment Suboxone film following a ruling of the US Court of Appeals for the Federal Circuit.

Indivior loses battle over Suboxone generic

22 November 2018 The US Court of Appeals for the Federal Circuit vacated a preliminary injunction against India-based Dr Reddy’s earlier this week, in a blow for addiction treatment drug producer Indivior.

Reckitt Benckiser to pay $1.4bn over opioid treatment sales

12 July 2019 Reckitt Benckiser has agreed to pay a $1.4 billion fine to settle a US investigation into the sales and marketing of opioid addiction treatment Suboxone film by its former prescriptions business.

More features

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?

Pfizer infringed haemophilia therapy patent, says court

Cooley adds ex-Gowling partner

Apple wins just $250 in Masimo smartwatch clash

Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar

Big Pharma counsel embrace AI but data and legal risks loom